UK authorizes Merck’s coronavirus treatment pill

no image added yet.

Merck (NYSE: MRK) today announced that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization in the United Kingdom (U.K.) for molnupiravir, the first oral antiviral medicine authorized for the treatment of mild-to-moderate COVID-19 in adults with a positive SARS-CoV-2 diagnostic test and who have at least one risk factor for developing severe illness.

“Today is a historic day for our country

Originally posted by Disclose.tv

© 2018 ARCHALIEN.TV All Rights Reserved.

Send this to a friend